| 1PEGylated Insulin |
|---|
Analyte not found
Applications
PEGylated Insulin on Jupiter® 300 C4, C18 and Two Experimental Columns
16193
Separation Mode: Reversed Phase
Reversed Phase
C4
HPLC
Pharmaceutical/Biopharmaceutical
Life Science
Biopharmaceutical
Therapeutic / Clinical
Analytes
Details
LC Conditions (App ID: 16193)
Column: | ||||||||||||
Brand Name: | ||||||||||||
Part No: | ||||||||||||
Phase Name: C4 | ||||||||||||
Elution Type: Gradient | ||||||||||||
Mobile Phase: A: 0.1% TFA and 2% ACN in Water B: 70/20% ACN/IPA, 0.08% TFA in Water | ||||||||||||
Gradient Profile:
| ||||||||||||
Flow Rate: 1 mL/min | ||||||||||||
Temperature: 45°C | ||||||||||||
Detection: UV-Vis Abs.-Variable Wave.(UV) @ 214 nm (22°C) | ||||||||||||
Sample Note: Reversed phase of PEGylated Insulin run on listed columns. Note the reduced resolution for the Jupiter C18 and EXP 2 columns when compared to the Jupiter C4 column. Although it is difficult to visualize, the Jupiter actully has better resolution of PEGylated forms than the EXP1 column. |
Order Items Used in This Application
00F-4167-E0
Jupiter 5 µm C4 300 Å, LC Column 150 x 4.6 mm, Ea
Qty:
Similar Applications
search
PEGylated Insulin
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
